ARCHIVES

Genentech Reps Not Welcome: Hospitals Urge Drug Maker to Reverse Policy On Supplying Avastin, Rituxan, & Herceptin

This article is from The Cancer Letter archive.

Vol. 40 No. 39 | October 17, 2014

Download PDF Visit The Full Archive

Related Articles

ASCO Releases Guideline On Use Of Growth Factors

May 26, 2006

In Brief: Gallo Lists Followup Projects For Human Cancer Virus; Zubrod Responds To Cancer Program Critics

April 11, 1975

FDA News: FDA Approves Reagent System for Graft-Versus-Host Disease

January 24, 2014

Four Detroit Institutions Merge Cancer Clinical, Research Programs

July 15, 1994

In Brief: General Murphy Resigns As Roswell Park Director; Penn.’s Richard Cooper Accepts Wisconsin Job

August 9, 1985

In Brief: Diagnostic Imaging Cost Declines By Half as Percentage Of Health Cost In 10 Years

January 11, 1985